Executive Management Team
Scott Whitaker, President & Chief Executive Officer
JC Scott, Chief Advocacy Officer
Jen Brearey, Chief Finance Officer
Janet Trunzo, Senior Executive Vice President, Technology & Regulatory Affairs
Andrew Fish, Chief Strategy Officer, AdvaMed; Executive Director, AdvaMedDx
Christopher L. White, Chief Operating Officer; General Counsel
Donald May, Executive Vice President, Payment & Health Care Delivery Policy
Ralph F. Ives, Executive Vice President, Global Strategy & Analysis
Ashley W. Wittorf, Executive Director, AdvaMed Accel; Global Head, Investor Relations
For a list of AdvaMed's board of directors, click here.
AdvaMed’s Policy Agenda is based upon four pillars and facilitated by AdvaMed Staff:
- Technology and Regulatory- Strives to improve the regulatory environment for member companies including such efforts as 510(k) reform, reauthorization of Medical Device User Fee Act (MDUFA), postmarket surveillance and enforcement, and global harmonization.
- Payment and Health Policy- Influences health care delivery and reimbursement policies to facilitate access to medical products and payment supporting innovation and value creation.
- Global Strategy and Analysis- Focuses on health care, trade, and medical technology regulatory and reimbursement issues in leading and key emerging world markets, and through international organizations.
- Legal and Compliance- Advocates for a predictable legal environment and focuses on areas such as Physician Payments Sunshine, Intellectual Property, Ethics and Compliance, Vendor Access, and the Medical Device Tax.
The General Counsel’s Office also oversees certification to the AdvaMed Code of Ethics, which clarifies and distinguishes appropriate and inappropriate activity between health care professionals and MedTech company representatives.